2011, Khavinson et al 2008), and with the linker histone protein H1 (H1.3 and H1.6) thereby influencing epigenetic regulation and expression of genes (Khavinson et al 2020)
Platonov AE, Sarksyan DS, Karan LS, Shipulin GA, Gordygina EV, Malinin OV, Maleev VV
10.1039/C7CP06829H
The same three authors proceeded to full-text screening, with any discrepancies resolved in the same manner
Scores on the Three-Factor Eating Questionnaire (TFEQ-R18) improved in all treatment groups, with Cagrilintide producing greater improvements than placebo in specific domains: cognitive restraint, notably at 1.2 mg and 4.5 mg, emotional eating notably at 0.3 mg and 2.4 mg, and uncontrolled eating notably at 1.24.5 mg
Suggested Usage Adults: One capsule, twice daily, or as directed by your healthcare provider